Slow responses to standard dose rituximab in immune thrombocytopenic purpura

door Kelly, Kevin, Gleeson, Mary, Murphy, Philip Thomas
Gepubliceerd in 2009

Cost (Non)-Recovery by Platform Technology Facilities in the Bio21 Cluster

door Gibbs, Gerard, Clark, Stella, Quinn, JulieAnne, Gleeson, Mary Joy
Gepubliceerd in 2010

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma

door Westerland, Olwen, Amlani, Ashik, Kelly-Morland, Christian, Fraczek, Michal, Bailey, Katherine, Gleeson, Mary, El-Najjar, Inas, Streetly, Matthew, Bassett, Paul, Cook, Gary J. R., Goh, Vicky
Gepubliceerd in Eur J Nucl Med Mol Imaging (2021)

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

door Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, Cunningham, David
Gepubliceerd in Lancet Haematol (2018)

Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London

door Russell, Beth, Moss, Charlotte, Papa, Sophie, Irshad, Sheeba, Ross, Paul, Spicer, James, Kordasti, Shahram, Crawley, Danielle, Wylie, Harriet, Cahill, Fidelma, Haire, Anna, Zaki, Kamarul, Rahman, Fareen, Sita-Lumsden, Ailsa, Josephs, Debra, Enting, Deborah, Lei, Mary, Ghosh, Sharmistha, Harrison, Claire, Swampillai, Angela, Sawyer, Elinor, D'Souza, Andrea, Gomberg, Simon, Fields, Paul, Wrench, David, Raj, Kavita, Gleeson, Mary, Bailey, Kate, Dillon, Richard, Streetly, Matthew, Rigg, Anne, Sullivan, Richard, Dolly, Saoirse, Van Hemelrijck, Mieke
Gepubliceerd in Front Oncol (2020)